These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12375546)

  • 1. Repeat postpartum magnesium sulfate administration for seizure prophylaxis: is there a patient profile predictive of need for additional therapy?
    Isler CM; Barrilleaux PS; Rinehart BK; Magann EF; Martin JN
    J Matern Fetal Neonatal Med; 2002 Feb; 11(2):75-9. PubMed ID: 12375546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of standard dose of magnesium sulphate in prophylaxis of eclamptic seizures: do body mass index alterations have any effect on success?
    Dayicioglu V; Sahinoglu Z; Kol E; Kucukbas M
    Hypertens Pregnancy; 2003; 22(3):257-65. PubMed ID: 14572362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective magnesium sulfate prophylaxis for the prevention of eclampsia in women with gestational hypertension.
    Alexander JM; McIntire DD; Leveno KJ; Cunningham FG
    Obstet Gynecol; 2006 Oct; 108(4):826-32. PubMed ID: 17012442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loading dose of magnesium sulphate versus standard regime for prophylaxis of pre-eclampsia.
    Shoaib T; Khan S; Javed I; Bhutta SZ
    J Coll Physicians Surg Pak; 2009 Jan; 19(1):30-3. PubMed ID: 19149977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open-labelled randomised controlled trial of 12 hours versus 24 hours modified Pritchard regimen in the management of eclampsia and pre-eclampsia in Ghana (MOPEP Study): study protocol.
    Beyuo T; Lawrence E; Langen ES; Oppong SA
    BMJ Open; 2019 Oct; 9(10):e032799. PubMed ID: 31641005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postpartum seizure prophylaxis: using maternal clinical parameters to guide therapy.
    Isler CM; Barrilleaux PS; Rinehart BK; Magann EF; Martin JN
    Obstet Gynecol; 2003 Jan; 101(1):66-9. PubMed ID: 12517647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The feasibility of a control population for a randomized control trial of seizure prophylaxis in the hypertensive disorders of pregnancy.
    Burrows RF; Burrows EA
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):929-35. PubMed ID: 7573271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eclampsia in Southern Alberta: is there a role for seizure prophylaxis in all women with gestational hypertension?
    Foong SC; Pollard JK
    J Obstet Gynaecol Can; 2003 May; 25(5):385-9. PubMed ID: 12738979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis of eclamptic seizures: current controversies.
    Repke JT; Friedman SA; Kaplan PW
    Clin Obstet Gynecol; 1992 Jun; 35(2):365-74. PubMed ID: 1638827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Audit can ensure the safe and effective introduction of seizure prophylaxis with magnesium sulphate in obstetric practice.
    Owen P
    Health Bull (Edinb); 2000 Sep; 58(5):414-7. PubMed ID: 12813796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loading Dose only versus Standard Dose Magnesium Sulfate Seizure Prophylaxis in Severe Pre-eclamptic Women.
    Rimal SP; Rijal P; Bhatt R; Thapa K
    JNMA J Nepal Med Assoc; 2017; 56(208):388-94. PubMed ID: 29453467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary function of preeclamptic women receiving intravenous magnesium sulfate seizure prophylaxis.
    Herpolsheimer A; Brady K; Yancey MK; Pandian M; Duff P
    Obstet Gynecol; 1991 Aug; 78(2):241-4. PubMed ID: 2067769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An audit of the use of magnesium sulphate in severe pre-eclampsia and eclampsia.
    Singh J; O'Donovan M; Coulter-Smith SD; Geary M
    J Obstet Gynaecol; 2005 Jan; 25(1):15-7. PubMed ID: 16147685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnesium sulfate for 6 vs 24 hours post delivery in patients who received magnesium sulfate for less than 8 hours before birth: a randomized clinical trial.
    Vigil-De Gracia P; Ramirez R; Durán Y; Quintero A
    BMC Pregnancy Childbirth; 2017 Jul; 17(1):241. PubMed ID: 28738788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnesium sulfate therapy in preeclampsia and eclampsia.
    Witlin AG; Sibai BM
    Obstet Gynecol; 1998 Nov; 92(5):883-9. PubMed ID: 9794688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective randomized trial of magnesium sulfate in severe preeclampsia: use of diuresis as a clinical parameter to determine the duration of postpartum therapy.
    Fontenot MT; Lewis DF; Frederick JB; Wang Y; DeFranco EA; Groome LJ; Evans AT
    Am J Obstet Gynecol; 2005 Jun; 192(6):1788-93; discussion 1793-4. PubMed ID: 15970809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abbreviated (12-hour) versus traditional (24-hour) postpartum magnesium sulfate therapy in severe pre-eclampsia.
    Maia SB; Katz L; Neto CN; Caiado BV; Azevedo AP; Amorim MM
    Int J Gynaecol Obstet; 2014 Sep; 126(3):260-4. PubMed ID: 24890747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postpartum seizure prophylaxis: using maternal clinical parameters to guide therapy.
    Fejgin MD; Goldberger SB
    Obstet Gynecol; 2003 Jul; 102(1):197; author reply 198. PubMed ID: 12850631
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of intrapartum magnesium sulfate therapy on fetal cardiac troponin I levels at delivery.
    Blackwell SC; Redman ME; Whitty JE; Refuerzo JS; Berry SM; Sorokin Y; Russell E; Cotton DB
    J Matern Fetal Neonatal Med; 2002 Nov; 12(5):327-31. PubMed ID: 12607765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia.
    Belfort MA; Anthony J; Saade GR; Allen JC;
    N Engl J Med; 2003 Jan; 348(4):304-11. PubMed ID: 12540643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.